Gamma Investing LLC Aurinia Pharmaceuticals Inc. Transaction History
Gamma Investing LLC
- $734 Billion
- Q2 2024
A detailed history of Gamma Investing LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 1,213 shares of AUPH stock, worth $8,806. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,213
Previous 2,769
56.19%
Holding current value
$8,806
Previous $13.9 Million
50.08%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AUPH
# of Institutions
191Shares Held
56.2MCall Options Held
499KPut Options Held
637K-
Armistice Capital, LLC New York, NY11.1MShares$80.8 Million0.83% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$67.3 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$28.8 Million2.14% of portfolio
-
State Street Corp Boston, MA2.88MShares$20.9 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.78MShares$20.2 Million1.94% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.03B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...